Scholars Central

Conference abstractPublished 29 Sep 2014

Anemia and risk factors in HAART naive and HAART experienced HIV positive participants in South West Ethiopia: A comparative study

Authors: Lealem Gedefaw, Tilahun Yemane, Zewdineh Sahlemariam, Daniel Yilma

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Human immunodeficiency virus (HIV) infection and its treatment cause a range of hematological abnormalities. Anemia is commonly observed and multifactorial in origin in HIV positive people and has been associated with increased mortality rates and disease progression. Objective: We aimed to determine the prevalence and risk factors of anemia in highly active antiretroviral therapy (HAART) naive and HAART experienced HIV positive people. Methods: A facility-based comparative cross sectional study was conducted in Jimma University Specialized Hospital from February 1 to March 30, 2012. A total of 234 HIV positive persons, 117 HAART naive and 117 HAART experienced, were enrolled in this study. Blood and stool specimens were collected from each participant for hematological, immunological and parasitological investigations. Socio-demographic characteristics and clinical data of patients were collected using pre-tested questionnaire. Statistical analysis of the data (Chi-square, student?s t-test, logistic regression) was done using SPSS V-16. Results: The overall prevalence of anemia was 23.1%. The prevalence of anemia in HAART naive and HAART experienced people was 29.9% and 16.2% respectively (P=0.014). Presence of opportunistic infections (P=0.004, 95%CI=1.69-15.46), CD4+<200 cells/μl (P=0.001, 95%CI=2.57-36.89) and rural residence (P=0.03, 95%CI=1.12-10.39) were found to be predictors of anemia for HAART naive participants. On the other hand, HAART regime (ZDV/3TC/NVP) and the duration of HAART were found to be predictors of anemia for HAART experienced groups. Conclusion: The prevalence of anemia in HAART naive patients was higher than HAART experienced patients. Risk factors for anemia in HAART naive and HAART experienced HIV positive persons were different. Hence, there is a need for a large scale and longitudinal study for further characterization of the type of HIV associated anemia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Lealem Gedefaw”
  • BylineArticles whose byline prints “Tilahun Yemane”
  • BylineArticles whose byline prints “Zewdineh Sahlemariam”
  • BylineArticles whose byline prints “Daniel Yilma”